Coloplast AS
http://www.coloplast.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Coloplast AS
Medtech Deals In Depth: November 2021
Major medtech deals in November include Coloplast's $2.5bn acquisition of Atos Medical and Alcon's deal for Ivantis.
Minute Insight: Coloplast Adds Neck Stoma Business By Acquiring Atos For $2.47M
The deal is part of Coloplast’s Strive25 long-term financial strategy for revenue growth and sustainability.
Boston Scientific’s Sec. 522 Studies On Pelvic Mesh Show It’s Too Risky, FDA Says
The US FDA says final data from two Boston Scientific postmarket studies have reinforced the agency’s position that the company’s transvaginal mesh to treat pelvic organ prolapse (POP) has a poor benefit-risk profile. The firm’s mesh has been off the US market since 2019.
Boston Scientific Pays $189M To Resolve Pelvic Mesh Cases
The settlement puts to rest product liability and patient safety suits in 47 states and the District of Columbia.
Company Information
- Industry
- Medical Devices